Evaluation of Pathologic Complete Response (pCR) to Neoadjuvant Chemotherapy in Iranian Breast Cancer Patients with Estrogen Receptor Positive and HER2 Negative and impact of predicting variables on pCR

OBJECTIVE: The pathologic complete response (pCR) in the breast and axillary lymph node after neoadjuvant chemotherapy (NAC) would improve outcomes and it is used as a surrogate marker for survival. Our objective was to evaluate the breast and nodal pCR in breast cancer patients with estrogen recept...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Breast Health
Autors principals: Omranipour, Ramesh, Jalili, Roghiyeh, Yazdankhahkenary, Adel, Assarian, Abdolali, Mirzania, Mehrzad, Eslami, Bita
Format: Artigo
Idioma:Inglês
Publicat: Turkish Federation of Breast Diseases Associations 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7337920/
https://ncbi.nlm.nih.gov/pubmed/32656523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/ejbh.2020.5487
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars